Table 2.
Age at diagnosis of T1D, years | Age at last clinical visit, years | Clinic | HLA | Race and ethnicity | Age at seroconversion, years | First appearing AAb | N of AAbs confirmed and persistent at seroconversion (0, 1, 2, 3, 4) | N of AAbs confirmed and persistent at diagnosis (0, 1, 2, 3, 4) | Enrolled or WD or LTFU (WD) | DKA severity (mild/moderate, severe, or unknown) | Polydipsia | Polyphagia | Polyuria | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 0.69 | 0.69 | Finland | DR3/4 | Non-Hispanic White | 0.50 | None | 0 | 0* | E | Severe | Unknown | Unknown | Unknown |
2 | 0.87 | 0.87 | WA | DR4/8 | Non-Hispanic White | 0.81 | GADAs, IAAs | 2 | 2 | E | Mild/moderate | Yes | No | Yes |
3 | 0.90 | 0.90 | Sweden | DR3/4 | Unknown | 0.54 | IAAs | 1 | 1 | E | Severe | Yes | Unknown | Yes |
4 | 0.97 | 0.97 | Sweden | DR3/4 | Unknown | 0.76 | GADAs, IAAs | 2 | 2 | E | Mild/moderate | Yes | No | Yes |
5 | 1.22 | 1.22 | CO | DR4/8 | Hispanic | 1.22 | IAAs | 1 | 1 | E | Severe | Yes | No | Yes |
6 | 1.43 | 1.43 | CO | DR3/4 | Hispanic | 1.29 | IAAs | 1 | 1 | E | Mild/moderate | Yes | No | Yes |
7 | 2.32 | 2.32 | Finland | DR3/4 | Non-Hispanic White | 1.85 | GADAs, IAAs | 2 | 3 | E | Mild/moderate | Yes | No | Yes |
8 | 2.47 | 2.47 | Germany | DR3/4 | Non-Hispanic White | 1.01 | GADAs, IAAs | 2 | 2 | E | Mild/moderate | Yes | No | Yes |
9 | 2.67 | 0.28 | WA | DR3/4 | Unknown | 0.28 | None | 0 | 0 | WD | Mild/moderate | Yes | Unknown | Yes |
10 | 3.07 | 1.75 | WA | DR3/4 | Hispanic | 1.10 | None | 0 | 0 | WD | Mild/moderate | Yes | Unknown | Yes |
11 | 3.38 | 3.38 | WA | DR4/4 | Non-Hispanic White | 2.53 | None | 0 | 0 | E | Mild/moderate | Yes | Yes | Yes |
12 | 3.92 | 1.42 | WA | DR3/4 | African American | 1.38 | None | 0 | 0 | WD | Mild/moderate | Yes | No | Yes |
13 | 4.99 | 4.99 | Germany | DR3/3 | Non-Hispanic White | 1.54 | GADAs | 1 | 4 | E | Mild/moderate | Unknown | Unknown | Unknown |
14 | 8.74 | 8.74 | Germany | DR4/4 | Non-Hispanic White | 8.74 | IA-2As, IAAs | 2 | 2 | WD | Mild/moderate | Yes | No | Yes |
15 | 8.92 | 8.92 | CO | DR3/4 | Hispanic | 0.25 | None | 0 | 0 | WD | Mild/moderate | Yes | Yes | Yes |
16 | 9.20 | 9.20 | CO | DR4/4 | Hispanic | 0.27 | None | 0 | 0 | WD | Mild/moderate | Yes | No | Yes |
17 | 9.86 | 9.86 | CO | DR3/4 | Hispanic | 6.46 | GADAs | 1 | 1 | E | Severe | Yes | No | Yes |
18 | 10.30 | 3.11 | FL/GA | DR3/4 | Non-Hispanic White | 2.74 | None | 0 | 0 | WD | Severe | Yes | Unknown | Yes |
19 | 10.61 | 10.61 | CO | DR3/4 | Hispanic | 6.24 | GADAs, ZnT8As | 2 | 4 | E | Mild/moderate | Yes | No | Yes |
20 | 10.87 | 10.87 | Finland | DR3/4 | Non-Hispanic White | 10.87 | GADAs, IA-2As | 2 | 2 | E | Mild/moderate | Yes | No | Yes |
21 | 11.31 | 11.31 | WA | DR4/8 | Other | 11.31 | IAAs | 1 | 1 | E† | Severe | Yes | No | Yes |
22 | 11.33 | 11.33 | Sweden | DR4/4 | Unknown | 0.75 | IAAs | 1 | 4 | WD | Mild/moderate | Yes | Unknown | Yes |
23 | 13.54 | 5.09 | WA | DR4/8 | Non-Hispanic White | 4.72 | None | 0 | 0* | WD | Mild/moderate | Yes | No | Yes |
AAb, autoantibody; E, enrolled; T1D, type 1 diabetes; ZnT8A, Zinc transporter 8 autoantibody.
Did not meet the TEDDY definition of persistent confirmed autoantibody positivity.
Participant WD from TEDDY then rejoined (enrolled) prior to T1D diagnosis.